A new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a faster recovery of COVID-19 patients and reduced mortality. On average, it took eight ...
Figure 3: IL-7 produced by non-BM–derived cells is important for CD8 + T cell proliferation in a lymphopenic host. Figure 4: IL-7R is required for CD8 + T cell survival in normal hosts.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback